ZyVersa Therapeutics, a biopharmaceutical company, appears to have released a document that is largely unreadable due to formatting issues or corruption. The content of the document is not discernible from the provided text, which contains a mix of PDF formatting strings and garbled characters. As such, no specific event, date, or status can be determined from the current announcement text.

ZyVersa Therapeutics, a biopharmaceutical company, appears to have released a document that is largely unreadable due to formatting issues or corruption. The content of the document is not discernible from the provided text, which contains a mix of PDF formatting strings and garbled characters. As such, no specific event, date, or status can be determined from the current announcement text.